INTENSIVE SPECIALTY HOSPITAL
1. Target Overview & Investment Thesis
INTENSIVE SPECIALTY HOSPITAL is a 250-bed rural/critical access in CADDO PARISH, LA with $54.8M in net patient revenue and a -11.7% operating margin. The hospital serves a payer mix of 64.4% Medicare, 20.7% Medicaid, and 14.9% commercial.
Thesis: Undervalued. Our ML models identify $4.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -11.7% to -4.3% (+736bps).
| Net Revenue HCRIS | $54.8M |
| Current EBITDA COMPUTED | $-6.4M |
| Operating Margin COMPUTED | -11.7% |
| Occupancy HCRIS | 43.8% |
| Revenue / Bed COMPUTED | $219K |
| Net-to-Gross HCRIS | 30.6% |
| Distress Probability ML | 57.3% |
2. Market Context & Competitive Position
LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of -11.7% places it below the state median. Among 32 size-comparable peers (125-500 beds), the median margin is -6.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (125-500), prioritizing same-state peers. 32 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| INTENSIVE SPECIALTY HOSPITAL (Target) | LA | 250 | $54.8M | -11.7% |
| UNIVERSITY MEDICAL CTR. AT NEW | LA | 310 | $671.3M | -22.4% |
| CHILDRENS HOSPITAL | LA | 189 | $523.4M | 6.7% |
| OUR LADY OF LOURDES RMC | LA | 363 | $509.6M | 8.9% |
| TULANE UNIVERSITY HOSPITAL & C | LA | 431 | $490.2M | -14.1% |
| LAFAYETTE GENERAL MEDICAL CENT | LA | 390 | $480.2M | -16.4% |
| BATON ROUGE GENERAL | LA | 251 | $445.5M | -6.7% |
| ST. TAMMANY PARISH HOSPITAL | LA | 213 | $434.6M | 4.5% |
| OCHSNER LSU HEALTH SHREVEPORT | LA | 273 | $395.6M | -50.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.1M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.1M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $667K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $35K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-6.4M |
| + RCM Uplift | +$4.0M |
| Pro Forma EBITDA | $-2.4M |
| Current Margin | -11.7% |
| Pro Forma Margin | -4.3% |
| WC Released (1x) | $2.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-9.8M | $-1.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-9.8M | $-5.2M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-8.9M | $4.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-8.9M | $2.8M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-10.8M | $-18.8M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-10.8M | $-24.2M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Heavy Medicare dependence | Medicare comprises 64.4% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
| High | Elevated distress probability | Model estimates 57.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 32 hospitals with 125-500 beds
- Same-state prioritization (n=33)
- Comp margins: P25=-15.3% / P50=-6.7% / P75=0.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.